Parisa Rahmani

Parisa Rahmani

Auto-generated profile, based on publicly available information

Parisa Rahmani

Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
PRParisa Rahmani
Parisa Rahmani
EMEbru Melekoglu
Ebru Melekoglu
STSogand Tavakoli
Sogand Tavakoli
NANasser Malekpour Alamdari
Nasser Malekpour Alamdari
PRPejman Rohani
Pejman Rohani
MSMohammadhassan Sohouli
Mohammadhassan Sohouli
Dyslipidemia/hyperlipidemia are among the risk factors for chronic diseases, especially cardiovascular diseases. Red Yeast Rice (RYR) herbal supplement may be helpful in improving serum fat levels ...

22 December 2021 in Urology Case Reports
Verified
Journal Article
Open access
PRParisa Rahmani
Parisa Rahmani
BABahar Ashjaee
Bahar Ashjaee
FZFatemeh Zamani
Fatemeh Zamani
PSParastoo Sharifi
Parastoo Sharifi
We report the case of a 16-year-old girl who complained of stomach discomfort. She's been on medical therapy for roughly 6 months after being diagnosed with Crohn's disease. Magnetic resonance enterography confirmed the diagnosis of an infected urachal cyst, and she eventually had surgery. The removed material had a significant chronic inflammatory and foreign body type granulomatous response, according to histology. Because urachal cyst is an uncommon disease, early identification requires a high level of suspicion, and urachal cyst should be included in the differential diagnosis.

1 January 2022 in Journal of Child Science
Verified
Journal Article
Open access
PDF file
PRParisa Rahmani
Parisa Rahmani
FFFatemeh Farahmand
Fatemeh Farahmand
GHGhobad Heidari
Ghobad Heidari
The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects.